REAP Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50
Closed -$2.41K 672
2024
Q4
$2.41K Hold
50
﹤0.01% 493
2024
Q3
$2.88K Buy
+50
New +$2.7K ﹤0.01% 497
2024
Q1
Sell
-174
Closed -$8.65K 660
2023
Q4
$8.65K Buy
+174
New +$8.51K ﹤0.01% 410

Other funds holding SNY

REAP Financial Group's SNY Position: Q1 2025 in Review

REAP Financial Group sold out of Sanofi (SNY) in Q1 2025, closing a stake of 50 shares — an estimated $2.41K sold.

REAP Financial Group first reported a position in SNY in Q4 2023 and held it in 3 quarters. The position peaked at $8.65K in Q4 2023. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • REAP Financial Group reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
  • REAP Financial Group sold 50 Sanofi shares in Q1 2025, an estimated $2.41K.
  • REAP Financial Group first reported a position in Sanofi in Q4 2023 and held it in 3 quarters.
  • REAP Financial Group's Sanofi position peaked at $8.65K in Q4 2023.
  • 771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on REAP Financial Group's 13F filing for Q1 2025, filed 14 May 2025.